Search results
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity...
Benzinga· 3 days agoTuesday, Eli Lilly And Co LLY reported first-quarter revenue of $8.77 billion, up 26% year over...
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip By Investing.com
Investing.com· 4 days agoAstellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023,...
Eli Lilly and Co (LLY) Q1 2024 Earnings Call Transcript Highlights: Stellar Growth and ...
GuruFocus.com via Yahoo Finance· 2 days agoDiscover how Eli Lilly and Co (LLY) achieved impressive Q1 results and raised its 2024 outlook, driven by strong product performance and strategic expansions.
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Zacks· 4 days agoInvestors are expected to focus on top and bottom-line growth when Collegium Pharmaceutical (COLL Quick QuoteCOLL - Free Report) reports first-quarter 2024 results on May 9, 2024. Collegium ...
JD Supra: Cozen Currents: Casting Trump II: The Sequel
JD Supra· 7 days agoA second Trump administration would likely include both familiar faces from his first term and newcomers, but a lack of institutional guardrails means that former President Trump’s personnel ...
Unveiling Cigna (CI) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 4 days agoFree Report) is predicted by Wall Street analysts to post quarterly earnings of $6.17 per share, reflecting an increase of 14.1% compared to the same period last year. Analysts expect 'Medical Care Ratio - Cigna Healthcare' to come in at 81.9%.
Eli Lilly and Co (LLY) Q1 2024 Earnings Call Transcript Highligh
Guru Focus· 3 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Q: Will tirzepatide be considered differently than a "weight loss drug" to secure Part D ...